Creo Medical GroupCMEOF 53 Days Inventory is 218.37 as of Dec. 2025, which is 17% below its 10-year median of 263.61. GuruFocus rates CMEOF with a GF Score™ of 53/100 and a GF Value™ of $0.25. The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Creo Medical Group ranks worse than 75.19% on this metric.
The historical rank and industry rank for Creo Medical Group's Days Inventory or its related term are showing as below:
CMEOF'
s Days Inventory Range Over the Past 10 Years
Min: 205.89 Med: 263.61 Max: 18660.63
Current: 283.89
During the past 11 years, Creo Medical Group's highest Days Inventory was 18660.63. The lowest was 205.89. And the median was 263.61.
CMEOF's Days Inventory is ranked worse than 75.19% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs CMEOF: 283.89
Creo Medical Group's Days Inventory
declined
from Dec. 2024 (790.15) to Dec. 2025 (218.37).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Creo Medical Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Creo Medical Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.76.
Creo Medical Group (OTCPK:CMEOF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Creo Medical Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Creo Medical Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Creo Medical Group Days Inventory Related Terms
Creo Medical Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Creo Medical Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Creo Medical Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creo Medical Group Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Creo Medical Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creo Medical Group (CMEOF) has a Days Inventory of 218.37 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Creo Medical Group and its competitors. This is 17% below median its historical median of 263.61. Over the past decade, Creo Medical Group's Days Inventory has ranged from 205.89 to 18,660.63. According to the industry distribution chart, Creo Medical Group ranks #591 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 75.2%.
Is Creo Medical Group's Days Inventory too high?
Creo Medical Group's current Days Inventory of 218.37 is 17% below median its 10-year median of 263.61. Over the past 10 years, this metric has ranged from a low of 205.89 to a high of 18,660.63. The Medical Devices & Instruments industry median Days Inventory is 179.60. Creo Medical Group's value of 218.37 is 21.6% above this industry median. Based on the distribution chart, Creo Medical Group ranks #591 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Creo Medical Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Creo Medical Group's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Creo Medical Group ranks #591 out of 786 companies for Days Inventory. This places Creo Medical Group in the lower half of its industry. The industry median Days Inventory is 179.60. Creo Medical Group's value of 218.37 is 21.6% above this benchmark. Historically, Creo Medical Group's own Days Inventory has ranged from 205.89 to 18,660.63 over the past decade. While the company's 10-year median is 263.61 vs. the industry median of 179.60, Creo Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Creo Medical Group's current Days Inventory of 218.37 is 21.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Creo Medical Group and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creo Medical Group's current Days Inventory is 218.37, which is 17% below median its own 10-year median of 263.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creo Medical Group stock overvalued right now?
Creo Medical Group (CMEOF) has a current Days Inventory of 218.37. The stock's GF Value™ is $0.25, compared to a current price of $0.20 — trading 20% below its estimated fair value. The current Days Inventory is 218.37, which is 17% below median its 10-year median of 263.61 and 21.6% above the Medical Devices & Instruments industry median of 179.60. Creo Medical Group's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Creo Medical Group (CMEOF), the current Days Inventory is 218.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creo Medical Group (CMEOF) Overvalued in 2026?
Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued.
The current stock price of $0.20 is trading 20% below its estimated GF Value™ of $0.25.
Key valuation signals for CMEOF:
Days Inventory: 218.37 (17% below median its 10-year median of 263.61)
GF Value™: $0.25 vs. price of $0.20 (20% below fair value)
Industry Position: 21.6% above the Medical Devices & Instruments median (#591 of 786)
No single metric tells the full story. See the CMEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
53GF Score
Get the complete analysis for CMEOF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMEOF has been successfully added to your 
